The cases in the HARMS Program learning modules are based on real cases and were specifically chosen to illustrate key principles when using urine drug testing in a primary care setting for chronic non-cancer pain.
The cases in the HARMS Program learning modules are based on real cases and were specifically chosen to illustrate key principles when using urine drug testing in a primary care setting for chronic non-cancer pain.
A tool for patients to use with their health care providers to help them decide what opioid agonist therapy (OAT) option would be best for them: sublingual buprenorphine (Suboxone), depot buprenorphine (Sublocade), methadone, or slow-release oral morphine (Kadian).
A tool for patients to use with their health care providers to help them decide what opioid agonist therapy (OAT) option would be best for them: sublingual buprenorphine (Suboxone), depot buprenorphine (Sublocade), methadone, or slow-release oral morphine (Kadian).
